Peter Ryser

bNovate Technologies SA is a water monitoring company based in Ecublens, Switzerland. The Swiss company specializes in developing custom-made instruments for clients and creating cell detection instruments for drinking water. The company's innovative water monitoring solutions include bactosense, bactosense multi, and aqu@sense, which can be used for multi-point water monitoring to detect bacteria in water throughout the water process line. The company also offers solutions for monitoring the purification steps of drinking water treatment, such as pre-treatment and filtration, with bactosense online and bactosense multi. Additionally, they provide aqu@sense mb for taking control of the microbiological quality of pharmaceutical water supplies. The company was founded in 2011 by Simon Künzi.

Sensile Technologies SA provides solutions for remote monitoring of meters and tank levels for the oil and gas industries. The firm offers its solutions for gas tank, oil and lubricant tank, petrol station, gas cylinders and meter. The company was founded by Sigfrid Strässler and Peter Ryser in 1999 and is headquartered in Morges, Switzerland.

Sensile Technologies SA provides solutions for remote monitoring of meters and tank levels for the oil and gas industries. The firm offers its solutions for gas tank, oil and lubricant tank, petrol station, gas cylinders and meter. The company was founded by Sigfrid Strässler and Peter Ryser in 1999 and is headquartered in Morges, Switzerland.

Sensile Technologies SA provides solutions for remote monitoring of meters and tank levels for the oil and gas industries. The firm offers its solutions for gas tank, oil and lubricant tank, petrol station, gas cylinders and meter. The company was founded by Sigfrid Strässler and Peter Ryser in 1999 and is headquartered in Morges, Switzerland.

bNovate Technologies SA is a water monitoring company based in Ecublens, Switzerland. The Swiss company specializes in developing custom-made instruments for clients and creating cell detection instruments for drinking water. The company's innovative water monitoring solutions include bactosense, bactosense multi, and aqu@sense, which can be used for multi-point water monitoring to detect bacteria in water throughout the water process line. The company also offers solutions for monitoring the purification steps of drinking water treatment, such as pre-treatment and filtration, with bactosense online and bactosense multi. Additionally, they provide aqu@sense mb for taking control of the microbiological quality of pharmaceutical water supplies. The company was founded in 2011 by Simon Künzi.

Part of Tandem Diabetes Care, Inc., AMF Medical SA is a Swiss medtech company that was founded in 2014. The company is based in St-Sulpice, Switzerland. The company is developing a novel technology called Sigi™, a next-generation interoperable, semi-reusable, and rechargeable patch pump that uses standard pre-filled insulin cartridges. Sigi™ is designed to make life easier for people with diabetes and received breakthrough device designation by the Food and Drug Administration in November 2021. The company is led by co-CEOs Mr. Pim van Wesel and Mr. Antoine Barraud, PhD, who is also a co-founder. AMF Medical was acquired by Tandem Diabetes Care, Inc. on January 19, 2023, for $205.05 million.

bNovate Technologies SA is a water monitoring company based in Ecublens, Switzerland. The Swiss company specializes in developing custom-made instruments for clients and creating cell detection instruments for drinking water. The company's innovative water monitoring solutions include bactosense, bactosense multi, and aqu@sense, which can be used for multi-point water monitoring to detect bacteria in water throughout the water process line. The company also offers solutions for monitoring the purification steps of drinking water treatment, such as pre-treatment and filtration, with bactosense online and bactosense multi. Additionally, they provide aqu@sense mb for taking control of the microbiological quality of pharmaceutical water supplies. The company was founded in 2011 by Simon Künzi.

Part of Tandem Diabetes Care, Inc., AMF Medical SA is a Swiss medtech company that was founded in 2014. The company is based in St-Sulpice, Switzerland. The company is developing a novel technology called Sigi™, a next-generation interoperable, semi-reusable, and rechargeable patch pump that uses standard pre-filled insulin cartridges. Sigi™ is designed to make life easier for people with diabetes and received breakthrough device designation by the Food and Drug Administration in November 2021. The company is led by co-CEOs Mr. Pim van Wesel and Mr. Antoine Barraud, PhD, who is also a co-founder. AMF Medical was acquired by Tandem Diabetes Care, Inc. on January 19, 2023, for $205.05 million.

Part of Tandem Diabetes Care, Inc., AMF Medical SA is a Swiss medtech company that was founded in 2014. The company is based in St-Sulpice, Switzerland. The company is developing a novel technology called Sigi™, a next-generation interoperable, semi-reusable, and rechargeable patch pump that uses standard pre-filled insulin cartridges. Sigi™ is designed to make life easier for people with diabetes and received breakthrough device designation by the Food and Drug Administration in November 2021. The company is led by co-CEOs Mr. Pim van Wesel and Mr. Antoine Barraud, PhD, who is also a co-founder. AMF Medical was acquired by Tandem Diabetes Care, Inc. on January 19, 2023, for $205.05 million.

Part of Tandem Diabetes Care, Inc., AMF Medical SA is a Swiss medtech company that was founded in 2014. The company is based in St-Sulpice, Switzerland. The company is developing a novel technology called Sigi™, a next-generation interoperable, semi-reusable, and rechargeable patch pump that uses standard pre-filled insulin cartridges. Sigi™ is designed to make life easier for people with diabetes and received breakthrough device designation by the Food and Drug Administration in November 2021. The company is led by co-CEOs Mr. Pim van Wesel and Mr. Antoine Barraud, PhD, who is also a co-founder. AMF Medical was acquired by Tandem Diabetes Care, Inc. on January 19, 2023, for $205.05 million.